Its effect on the CSC population in BC was evaluated and it was found that DSF eradicates BCSC, inhibits CSC marker expression such as SOX2 and OCT4, and reverses PTX and cisplatin resistance in MDA-MB-231 PAC10 cells (resistant to cytotoxicity) [125]. The gene discussed is SOX2; the disease is breast cancer.